SARS-CoV-2-IN-110
Product Specifications
Target
SARS-CoV
Related Pathways
Microbiology/Virology
Bioactivity
SARS-CoV-2-IN-110 (compound Bb1) is an inhibitor of SARS-CoV-2, demonstrating antiviral efficacy with an EC50 of 1.10 ?M, and significantly reduced toxicity compared to Lapatinib. The compound exhibits a CC50 of greater than 100 ?M against SARS-CoV-2, with a selectivity index (SI) exceeding 91.
Molecular Formula
C28H20ClFN4O2
Molecular Weight
498.94
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1086133-01 0.02 mg (E-Coli)
Recombinant Treponema pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details 
MBS1086133-02 0.1 mg (E-Coli)
Recombinant Treponema pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details MBS1086133-03 0.02 mg (Yeast)
Recombinant Treponema pallidum Peptidyl-tRNA hydrolase (pth)
Ask
View Details